This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Di Fiore, P P Articles by Aaronson, S A Search for Related Content PubMed PubMed Citation Articles by Di Fiore, P P Articles by Aaronson, S A

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 June; 10(6): 2749-2756

The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.

Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The erbB-2 gene product, gp185erbB-2, displays a potent transforming effect when overexpressed in NIH 3T3 cells. In addition, it possesses constitutively high levels of tyrosine kinase activity in the absence of exogenously added ligand. In this study, we demonstrate that its carboxy-terminal domain exerts an enhancing effect on erbB-2 kinase and transforming activities. A premature termination mutant of the erbB-2 protein, lacking the entire carboxy-terminal domain (erbB-2 delta 1050), showed a 40-fold reduction in transforming ability and a lowered in vivo kinase activity for intracellular substrates. When the carboxy-terminal domain of erbB-2 was substituted for its analogous region in the epidermal growth factor receptor (EGFR) (EGFR/erbB-2COOH chimera), it conferred erbB-2-like properties to the EGFR, including transforming ability in the absence of epidermal growth factor, elevated constitutive autokinase activity in vivo and in vitro, and constitutive ability to phosphorylate phospholipase C-gamma. Conversely, a chimeric erbB-2 molecule bearing an EGFR carboxy-terminal domain (erbB-2/EGFRCOOH chimera) showed reduced transforming and kinase activity with respect to the wild-type erbB-2 and was only slightly more efficient than the erbB-2 delta 1050 mutant. Thus, we conclude that the carboxy-terminal domains of erbB-2 and EGFR exert different regulatory effects on receptor kinase function and biological activity. The up regulation of gp185erbB-2 enzymatic activity exerted by its carboxy-terminal domain can explain, at least in part, its constitutive level of kinase activity.

This article has been cited by other articles:

• Northey, J. J., Chmielecki, J., Ngan, E., Russo, C., Annis, M. G., Muller, W. J., Siegel, P. M. (2008). Signaling through ShcA Is Required for Transforming Growth Factor {beta}- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion. Mol. Cell. Biol. 28: 3162-3176 [Abstract] [Full Text]  
• Emanuel, S. L., Hughes, T. V., Adams, M., Rugg, C. A., Fuentes-Pesquera, A., Connolly, P. J., Pandey, N., Moreno-Mazza, S., Butler, J., Borowski, V., Middleton, S. A., Gruninger, R. H., Story, J. R., Napier, C., Hollister, B., Greenberger, L. M. (2008). Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors. Mol. Pharmacol. 73: 338-348 [Abstract] [Full Text]  
• Innocenti, M., Frittoli, E., Ponzanelli, I., Falck, J. R., Brachmann, S. M., Di Fiore, P. P., Scita, G. (2003). Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J. Cell Biol. 160: 17-23 [Abstract] [Full Text]  
• Piccinini, G., Bacchiocchi, R., Serresi, M., Vivani, C., Rossetti, S., Gennaretti, C., Carbonari, D., Fazioli, F. (2002). A Ligand-inducible Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase Chimera Promotes Mitogenesis and Transforming Properties in 3T3 Cells. J. Biol. Chem. 277: 22231-22239 [Abstract] [Full Text]  
• Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., Muller, W. J. (2001). Grb2 and Shc Adapter Proteins Play Distinct Roles in Neu (ErbB-2)-Induced Mammary Tumorigenesis: Implications for Human Breast Cancer. Mol. Cell. Biol. 21: 1540-1551 [Abstract] [Full Text]  
• Fiorentino, L., Pertica, C., Fiorini, M., Talora, C., Crescenzi, M., Castellani, L., Alemà, S., Benedetti, P., Segatto, O. (2000). Inhibition of ErbB-2 Mitogenic and Transforming Activity by RALT, a Mitogen-Induced Signal Transducer Which Binds to the ErbB-2 Kinase Domain. Mol. Cell. Biol. 20: 7735-7750 [Abstract] [Full Text]  
• Ram, T. G., Schelling, M. E., Hosick, H. L. (2000). Blocking HER-2/HER-3 Function with a Dominant Negative Form of HER-3 in Cells Stimulated by Heregulin and in Breast Cancer Cells with HER-2 Gene Amplification. Cell Growth Differ. 11: 173-183 [Abstract] [Full Text]  
• Kassis, J., Moellinger, J., Lo, H., Greenberg, N. M., Kim, H.-G., Wells, A. (1999). A Role for Phospholipase C-{{gamma}}-mediated Signaling in Tumor Cell Invasion. Clin. Cancer Res. 5: 2251-2260 [Abstract] [Full Text]  
• Torrisi, M. R., Lotti, L. V., Belleudi, F., Gradini, R., Salcini, A. E., Confalonieri, S., Pelicci, P. G., Di Fiore, P. P. (1999). Eps15 Is Recruited to the Plasma Membrane upon Epidermal Growth Factor Receptor Activation and Localizes to Components of the Endocytic Pathway during Receptor Internalization. Mol. Biol. Cell 10: 417-434 [Abstract] [Full Text]  
• Coda, L., Salcini, A. E., Confalonieri, S., Pelicci, G., Sorkina, T., Sorkin, A., Pelicci, P. G., Di Fiore, P. P. (1998). Eps15R Is a Tyrosine Kinase Substrate with Characteristics of a Docking Protein Possibly Involved in Coated Pits-mediated Internalization. J. Biol. Chem. 273: 3003-3012 [Abstract] [Full Text]  
• Cohen, B. D., Kiener, P. A., Green, J. M., Foy, L., Fell, H. P., Zhang, K. (1996). The Relationship between Human Epidermal Growth-like Factor Receptor Expression and Cellular Transformation in NIH3T3 Cells. J. Biol. Chem. 271: 30897-30903 [Abstract] [Full Text]  
• Riese, D. J. II, Kim, E. D., Elenius, K., Buckley, S., Klagsbrun, M., Plowman, G. D., Stern, D. F. (1996). The Epidermal Growth Factor Receptor Couples Transforming Growth Factor-alpha , Heparin-binding Epidermal Growth Factor-like Factor, and Amphiregulin to Neu, ErbB-3, and ErbB-4. J. Biol. Chem. 271: 20047-20052 [Abstract] [Full Text]  
• Baulida, J., Kraus, M. H., Alimandi, M., Di Fiore, P. P., Carpenter, G. (1996). All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired. J. Biol. Chem. 271: 5251-5257 [Abstract] [Full Text]  
• Scita, G., Tenca, P., Areces, L. B., Tocchetti, A., Frittoli, E., Giardina, G., Ponzanelli, I., Sini, P., Innocenti, M., Di Fiore, P. P. (2001). An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J. Cell Biol. 154: 1031-1044 [Abstract] [Full Text]  
• Innocenti, M., Tenca, P., Frittoli, E., Faretta, M., Tocchetti, A., Di Fiore, P. P., Scita, G. (2002). Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J. Cell Biol. 156: 125-136 [Abstract] [Full Text]